Literature DB >> 29128633

PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.

Zhiwang Song1, Chan Feng1, Yonglin Lu1, Yun Lin2, Chunyan Dong3.   

Abstract

PURPOSE: To investigate the expression, clinical significance, biological function, and the potential mechanism of PHGDH in pancreatic cancer.
METHODS: The expression of PHGDH in human pancreatic cancer tissues and corresponding adjacent normal tissues were analyzed through immunohistochemistry staining. Simultaneously, the association between the PHGDH expression and the clinicopathological parameters and OS and DFS was evaluated. Human pancreatic cancer cell line BxPC-3 and SW1990 were selected to investigate the effect of PHGDH knockdown on cell proliferation, migration, and invasion. In addition, we performed western blot to assess the expression of cyclin B1, and cyclin D1, MMP-2, and MMP-9 protein.
RESULTS: Our results suggested that the expression of PHGDH is increased in pancreatic cancer compared with adjacent normal tissues and the increased expression of PHGDH is associated with tumor size, lymph node metastasis, and TNM state of pancreatic cancer patients. Moreover, the expression of PHGDH is an independent prognostic indicator for pancreatic cancer patients. In addition, we found that knockdown of PHGDH in pancreatic cancer cells inhibits the cell proliferation, migration, and invasion abilities by down-regulating the expression of cyclin B1, and cyclin D1, MMP-2, and MMP-9.
CONCLUSIONS: Our data indicated that the expression of PHGDH is increased in pancreatic cancer and is an independent molecular prognostic factor for pancreatic cancer patients. In addition, PHGDH controls cell proliferation, migration and invasion abilities. Therefore, PHGDH could serve as an important prognostic indicator and therapeutic target for pancreatic cancer.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pancreatic cancer; Phosphoglycerate dehydrogenase (PHGDH); Prognosis; Proliferation

Mesh:

Substances:

Year:  2017        PMID: 29128633     DOI: 10.1016/j.gene.2017.11.014

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  26 in total

1.  The PHGDH enigma: Do cancer cells only need serine or also a redox modulator?

Authors:  Albert M Li; Jiangbin Ye
Journal:  Cancer Lett       Date:  2020-02-04       Impact factor: 8.679

2.  UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.

Authors:  Zhiwang Song; Junhe Li; Ling Zhang; Jun Deng; Ziling Fang; Xiaojun Xiang; Jianping Xiong
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

3.  Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.

Authors:  Yuping Tan; Xia Zhou; Yanqiu Gong; Kun Gou; Youfu Luo; Da Jia; Lunzhi Dai; Yinglan Zhao; Qingxiang Sun
Journal:  Cell Mol Life Sci       Date:  2021-12-31       Impact factor: 9.261

4.  Knockdown of PHGDH potentiates 5-FU cytotoxicity in gastric cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway.

Authors:  Yunli Zhang; Litao Yang; Guangou Dai; Hu Cao
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 5.  3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.

Authors:  Mingxue Li; Canrong Wu; Yueying Yang; Mengzhu Zheng; Silin Yu; Jinhui Wang; Lixia Chen; Hua Li
Journal:  Cell Oncol (Dordr)       Date:  2021-03-18       Impact factor: 6.730

Review 6.  The metabolism of cancer cells during metastasis.

Authors:  Gabriele Bergers; Sarah-Maria Fendt
Journal:  Nat Rev Cancer       Date:  2021-01-18       Impact factor: 60.716

7.  Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.

Authors:  Yuan Fan; Xingchen Li; Li Tian; Jianliu Wang
Journal:  Front Oncol       Date:  2021-03-08       Impact factor: 6.244

Review 8.  Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival.

Authors:  Jacinta Serpa
Journal:  Front Oncol       Date:  2020-06-23       Impact factor: 6.244

9.  Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer.

Authors:  Xiaoya Zhao; Jianfei Fu; Wanfen Tang; Liangliang Yu; Wenxia Xu
Journal:  Onco Targets Ther       Date:  2020-05-29       Impact factor: 4.147

10.  One carbon metabolism in human lung cancer.

Authors:  Sha Yao; Luogen Peng; Omar Elakad; Stefan Küffer; Marc Hinterthaner; Bernhard C Danner; Alexander von Hammerstein-Equord; Philipp Ströbel; Hanibal Bohnenberger
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.